Answers are grounded in this paper and cite their sources.
In the current scenario, treatment of diabetes has become individualized and patient centric with customization of therapy being the key. Selection and adoption of insulin therapy now is driven by many factors like patient preference, co-morbid conditions, patient education and availability of insulin and cost of therapy [1]. This review attempts to discuss the rational use of different types of insulins in different situations
No takes yet. Share an insight, caveat, or question.
Arundhati Dasgupta (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: